Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wolters

Showing results (61-70 of 253) with videos related to

Pageof 26
Sort By:
Acta Neurologica Scandinavica|September 1, 1986
Mononuclear cell subpopulations in cerebrospinal fluidC H Polman, C J de Groot, T Sminia, et al.
Clinical Neuropharmacology|April 1, 1989
Clozapine: an antipsychotic agent in Parkinson's disease?E C Wolters, T A Hurwitz, R F Peppard, et al.
Journal of the Neurological Sciences|July 1, 1993
Whole blood monoamine oxidase activity in Parkinson's disease and multiple system atrophy patientsM A Kuiper, C H Konings, P L Bergmans, et al.
Advances in Neurology|January 1, 1993
Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study GroupE C Wolters, M W Horstink, R A Roos, et al.
Synapse (New York, N.Y.)|February 17, 2001
Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's diseaseJ Booij, P Bergmans, A Winogrodzka, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
IBZM- and CIT-SPECT of the dopaminergic system in parkinsonismG Tissingh, J Booij, A Winogrodzka, et al.
Addictive Behaviors|October 2, 2009
Heritability of cannabis initiation in Dutch adult twinsJacqueline M Vink, Liselot M C Wolters, Michael C Neale, et al.
Neurology|May 1, 1995
Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal agingP Scheltens, F Barkhof, D Leys, et al.
JAMA|August 6, 2000
Factors associated with tobacco sales to minors: lessons learned from the FDA compliance checksP I Clark, S L Natanblut, C L Schmitt, et al.
Neurology|October 1, 1996
Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's diseaseE C Wolters, E N Jansen, H G Tuynman-Qua, et al.
Pageof 26

Showing results (61-70 of 253) with videos related to

Sort By:
Pageof 26
Acta Neurologica Scandinavica|September 1, 1986
Mononuclear cell subpopulations in cerebrospinal fluidC H Polman, C J de Groot, T Sminia, et al.
Clinical Neuropharmacology|April 1, 1989
Clozapine: an antipsychotic agent in Parkinson's disease?E C Wolters, T A Hurwitz, R F Peppard, et al.
Journal of the Neurological Sciences|July 1, 1993
Whole blood monoamine oxidase activity in Parkinson's disease and multiple system atrophy patientsM A Kuiper, C H Konings, P L Bergmans, et al.
Advances in Neurology|January 1, 1993
Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study GroupE C Wolters, M W Horstink, R A Roos, et al.
Synapse (New York, N.Y.)|February 17, 2001
Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's diseaseJ Booij, P Bergmans, A Winogrodzka, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
IBZM- and CIT-SPECT of the dopaminergic system in parkinsonismG Tissingh, J Booij, A Winogrodzka, et al.
Addictive Behaviors|October 2, 2009
Heritability of cannabis initiation in Dutch adult twinsJacqueline M Vink, Liselot M C Wolters, Michael C Neale, et al.
Neurology|May 1, 1995
Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal agingP Scheltens, F Barkhof, D Leys, et al.
JAMA|August 6, 2000
Factors associated with tobacco sales to minors: lessons learned from the FDA compliance checksP I Clark, S L Natanblut, C L Schmitt, et al.
Neurology|October 1, 1996
Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's diseaseE C Wolters, E N Jansen, H G Tuynman-Qua, et al.
Pageof 26